Investigational Site Number : 7240011
Madrid 28040
1 studies enrolling now · 2 studies all time
What they study most
Asthma, Type 1 Diabetes Mellitus
Studies at this site
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
— Recruiting now
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
— Running, not enrolling